Transcription
Adam Pener 0:06
My name is Adam Pener, I am CEO of MaskZero makers of the world's only and patented virus killed technology for personal protective devices. MaskZero is being presented here at LSI for the first time in public anywhere in the world. And what our mask does specifically is it allows both healthcare providers to work in a safe environment all day that is comfortable, lightweight, and proven to kill virus at the point of breath. Also, the product serves as a insurance piece for a future pandemic, in the event that millions of people need to put on a mask that they can feel confidently will not transmit either a virus to the person wearing the mask or if the person is infected from the mask to a non where the device was inspired by the pandemic, our founder started to do research and determine that science understood that you could kill a virus using a specific type of UVC. So we met over zoom during the pandemic and developed very quickly a partnership and patented the product in June of 2020. And that was two months before three major and one fortune 500 company all tried to patent the same technology. So we hit it very fast, we started to work on the product, which is a class two medical device. And we are now three years into product development, small batch manufacturing is underway. The small batch units will look like this one on here. This is a 3d printed prototype. And we expect FDA approval this fall and come into market in early 2024. So from the very beginning, we knew that MaskZero is going to be a product that in certain events would need to be off grid, so you wouldn't be able to plug it in to access the virus kill technology. So we decided to do something unique, which is to go back to old fashioned batteries, which we know will be available in a situation like that. The founder was thinking through all of the devices that were available in the marketplace. And he was very focused on form fit function and comfort for all day wear. So we spent at least four months focused on nothing more than anthropometric design, where we went through just shape after shape and designed to get the perfect shape for somebody to be able to wear it is extremely lightweight, this is less than two pounds. And then we have the ceiling function. So we knew that people cannot wear a scuba type shield for 12 hours. So we have a seal and that way virus cannot get into the mask when the wearer is using it with that. And also we focused heavily on a CPAP style strap, which allows for comfort because everyone now understands that headache they get from the the N 95 masks coming over here. What has resulted is MaskZero and MaskZero has a very specific place in the marketplace. It is less expensive than n95s worn for an entire year with a plastic shield by your average nurse or nurse or healthcare worker. And it's also way less expensive than a respirator, which oftentimes will impede communication between the user and the provider. That was very important to us. So early on, we had a great conversation with a Johnson and Johnson executive who said, I will take one of those right now without the virus killed technology, because I can't communicate with my customers. So again, you look at this and put it on. And you can both hear me when I'm wearing the mask. But more importantly, you can see my facial expressions, which is incredibly important in a healthcare environment. MaskZero will be formally in the market after FDA approval in early 2024. We're extremely excited for the opportunity to speak with both strategic partners, many of the VCs that are out there that are hospital units, but also the hospitals and providers themselves. early on. We have done a number of usability studies and have had tremendous end user response to this. I'd also like to give a personal thank you to the University of Colorado and chutes, which has been an incredible partner throughout this and specifically their combat unit run by Colonel Vic BARDA, who has been a leading advocate for our technology and is helping us put it on the faces of people who are actually going to be wearing it. This is incredibly important for healthcare technology to make sure that you're not just making something cool. You're making something that adds value and that people want to wear and they feel safer wearing it and in a in a pandemic scenario. For a long time we've been discussing when is the right time to present this technology to the public and start to get the feedback from not only potential end users but also strategic players in the marketplace, hospitals others LSI is the world's premier event for this the the caliber of people walking around this event and having the opportunity to have these conversations, not only about massira but in general, what's going on in the medical industry made this a very easy sell for us. So we sat down we said, Okay, we've got the patent in place. It's time to come here and get some feedback and start to show people what we have
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
